Kindbody Cuts Fertility Costs Through Clinics

Owning the clinic lets Kindbody keep the money that a navigator passes through to someone else. Instead of collecting a fee while outside IVF centers do the procedures, Kindbody can bill for the visit, the lab workflow, and the treatment itself inside one system, which is why it can price below traditional clinics and still target much higher gross margins than benefits led peers like Progyny.1 2 3 4 5

• The practical difference is where care happens. Maven and Progyny largely steer members into outside provider networks, while Kindbody owns clinic capacity and also contracts directly with employers. That means one operator controls scheduling, intake, benefits checks, care navigation, and the IVF cycle, which reduces handoffs and captures more revenue per patient.1 2 3 4
• The margin gap shows up in the numbers. Kindbody was estimated at about 60% gross margin on $180M of 2023 revenue, versus Progyny at roughly 20% to 24% gross margin on a much larger pass through benefits business. That supports the idea that clinic ownership can be more profitable when utilization stays high.1 2 5
• Technology matters because fertility care is admin heavy. Kindbody says its platform handles patient intake, care navigation, benefits coordination, cost visibility, and AI supported workflows. In a fertility clinic, every fewer phone call, form, and manual charting step lowers labor cost and makes lower pricing more sustainable.1 6 7

The next phase is turning owned clinics into a lower cost employer channel at national scale. As Kindbody combines its signature clinics with a broader partner network and software layer, the company is positioning clinic ownership not as a local care model, but as the engine for a managed fertility benefit with tighter pricing and better unit economics.2 6 7